Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism

Fertility and Sterility

Volumn 79, Issue 4, 2003, Pages 942-946

  Lumachi, Franco ^a   Rondinone, Riccardo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Androgens; Cyproterone acetate; Finasteride; Idiopathic hirsutism; Spironolactone

Indexed keywords

CYPROTERONE ACETATE; FINASTERIDE; ORAL CONTRACEPTIVE AGENT; SPIRONOLACTONE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HIRSUTISM; HUMAN; METHODOLOGY; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0037382633     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)04927-0     Document Type: Article

References (21)

1. Hatch R., Rosenfield R.L., Kim M.H., Tredway D. Hirsutism implications, etiology, and management . Am J Obstet Gynecol. 140:1981;815-830.
2. Azziz R., Carmina E., Sawaya M.E. Idiopathic hirsutism. Endocrinol Rev. 21:2000;347-362.
3. Knochenhauser E.S., Azziz R. Advances in the diagnoses and treatment of the hirsute patients. Curr Opin Obstet Gynecol. 7:1995;344-350.
4. Ferriman D., Gallwey J.D. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 21:1961;1440-1447.
5. Azziz R., Waggoner W.T., Ochoa T., Knochenhauer E.S., Boots L.R. Idiopathic hirsutism an uncommon cause of hirsutism in Alabama . Fertil Steril. 70:1998;274-278.
6. Goldfien A. Ovaries. Greenspan F.S., Gardner F. Basic & clinical endocrinology. 2001;453-508 McGraw-Hill, New York.
7. Ebling F.J. Hair follicles and associated glands as androgen targets. Clin Endocrinol Metab. 15:1986;319-339.
8. Cassidenti D.L., Paulson R.J., Serafini P., Stanczyk F.Z., Lobo P. Effects of sex steroids on skin 5α-reductase activity in vitro. Obstet Gynecol. 78:1991;103-107.
9. Hamada K., Thornton M.J., Laing I., Messenger A.G., Randall V.A. The metabolism of testosterone by dermal papilla cells cultured from human pubic and axillary hair follicles concurs with hair growth in 5α-reductase deficiency. J Invest Dermatol. 106:1996;1017-1022.
10. Peereboom-Wynia J.D.R., Boekhorst J.C. Effect of cyproterone acetate orally in hair density and diameter and endocrine factors in women with idiopathic hirsutism. Dermatologica. 160:1980;7-16.
11. Barth J.H., Cherry C.A., Wojnarowska F., Dawber R.P. Cyproterone acetate for severe hirsutism results of a double-blind dose-ranging study . Clin Endocrinol. 35:1991;5-10.
12. Venturoli S., Marescalchi O., Colombo F.M., Macelli S., Ravaioli B., Bagnoli A., et al. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism. J Clin Endocrinol Metab. 84:1999;1304-1310.
13. Vasilakis-Scaramozza C., Jick H. Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. Lancet. 358:2001;1427-1429.
14. Rittmaster R.S. Finasteride. N Engl J Med. 330:1994;120-125.
15. Moghetti P., Castello R., Magnani C.M., Tosi F., Negri C., Armanini D., et al. Clinical and hormonal effects of the 5-alpha reductase inhibitor finasteride in idiopathic hirsutism. J Clin Endocrinol Metab. 79:1994;1115-1121.
16. Ciotta L., Cianci A., Calogero A., Palumbo M.A., Marletta E., Sciuto A., et al. Clinical and endocrine effects of finasteride, a 5alpha-reductase inhibitor in women with idiopathic hirsutism. Fertil Steril. 64:1995;299-306.
17. Tolino A., Petrone A., Sarnacchiaro F., Cirillo D., Ronsini S., Lombardi G., et al. Finasteride in the treatment of hirsutism new therapeutic perspectives . Fertil Steril. 66:1996;61-65.
18. Castello R., Tosi F., Perrone F., Negri C., Muggeo M., Moghetti P. Outcome of long-term treatment with the 5-alpha reductase inhibitor finasteride in idiopathic hirsutism. Clinical and hormonal effects during a 1 year course of therapy and 1 year follow-up. Fertil Steril. 66:1996;734-740.
19. Faloia E., Filipponi S., Mancini V., Di Marco S., Mantero F. Effects of finasteride in idiopathic hirsutism. J Endocrinol Invest. 21:1998;694-698.
20. Erenus M., Yücelten D., Gürbüz O., Durmusoglu F., Pekin S. Comparison of spironolactone-oral contraceptive vs. cyproterone acetate-estrogen regimens in the treatment of hirsutism. Fertil Steril. 66:1996;216-219.
21. Erenus M., Yücelten D., Durmusoglu F., Gürbüz O. Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism. Fertil Steril. 68:1997;1000-1003.